Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Emerging Approaches in Schizophrenia
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Bruce Alexander, PharmD
JCP
Original Research
Clozapine Exposure and Risk of Hematologic Malignancies in Veterans with Schizophrenia
May 15, 2024
Clozapine exposure of at least 5 years was associated with hematologic malignancy, and the increased risk was dose-dependent.
Delaney R. Brainerd
,
Bruce Alexander
,
Marshall J. Tague
, et al
JCP
Original Research
Prazosin Dosing for PTSD Treatment
May 27, 2015
Read an article examining a cohort of veterans with PTSD initiating prazosin to characterize their typical duration of use and dosing patterns.
Bruce Alexander
,
Brian C. Lund
,
Nancy C. Bernardy
, et al
JCP
Letter to the Editor
Dr Lund and Colleagues Reply
August 15, 2013
Brian C. Lund
,
Nancy C. Bernardy
,
Bruce Alexander
, et al
JCP
Original Research
Prescribing Trends in Veterans With Posttraumatic Stress Disorder
March 15, 2012
Nancy C. Bernardy
,
Brian C. Lund
,
Bruce Alexander
, et al
JCP
Original Research
Declining Benzodiazepine Use in Veterans With Posttraumatic Stress Disorder
November 29, 2011
Brian C. Lund
,
Nancy C. Bernardy
,
Bruce Alexander
, et al
